| CYSB2200235 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-28 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400219 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-08-17 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2200229 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2200289 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-12-27 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2101163 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-08-20 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2500100 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2025-05-13 | | Gan & Lee Pharmaceuticals;Gan&Lee Pharmaceuticals Shandong Co Ltd | | | view |
| CYSB2300217 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-11-29 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2200228 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400166 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | Supplementary Application | 2024-07-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CXSS2200007 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2022-01-26 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CYSB2400323 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-12-13 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2101240 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2021-10-27 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSL2300177 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-03-08 | | Nanjing Han Xin Pharmaceutical Technology Co Ltd | | | view |
| CYSB2101177 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-09-06 | | Gan & Lee Pharmaceuticals | | | view |
| CXSS2101010 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.4) | New Drug Application | 2021-07-13 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400063 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-03-08 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2200005 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSL2200053 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2022-01-27 | | Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| CYSB2500061 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2025-03-22 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2101104 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-06-25 | | Gan & Lee Pharmaceuticals | | | view |
